1 |
What is the primary function of AI in the medical imaging industry?
|
To improve diagnostic accuracy and patient outcomes |
|
AI can analyze faster ad more accurately than human |
AI is to support doctor to help with decisions |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
2 |
Which of the following is a key benefit of AI in radiology noted in the article?
|
Acts as a second medical opinion |
|
They provide additional thing to identify issue more accurately |
Confirming diagnosis better and improve the outcome |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
3 |
What does AI literacy refer to according to the article?
|
Understanding and knowledge of AI technology |
|
Meaning understand how AI work and use it correctly |
It foucus on function and its responsibilities only |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
4 |
Which factor is NOT listed as influencing the acceptability of AI among healthcare professionals?
|
The color of the AI machines |
|
Color of machine doesn't influence anything |
The physical appearance that doesn't matter |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
5 |
What role does social influence play in AI acceptability in healthcare according to the article?
|
Affects healthcare professionals’ decisions to use AI |
|
Social influence plays the major role in shaping the healthcare |
Social influence can impact to accepting and using AI |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
6 |
What is a perceived threat regarding AI usage in healthcare settings?
|
Concerns about replacing healthcare professionals |
|
Fear that I may replace human job |
Many people fear that AI will replace them |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
7 |
According to the article, what is essential for increasing AI acceptability among medical professionals?
|
Designing human-centred AI systems |
|
I think to increase Ai acception may help |
Human centered design to make sure to tools are trustworthy and supportive not replacing |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
8 |
What does the 'system usage' category of AI acceptability factors include according to the article?
|
Factors like value proposition and integration with workflows |
|
Because it show how well AI is to help practicing in medical and many stuff in medical field |
Both factor impact Healthcare system more likely to apodt and accept the AI system |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
9 |
How does ethicality impact AI acceptability among healthcare professionals?
|
Affects views on AI based on compatibility with professional values |
|
To access Healthcare provider |
To access Healthcare provider on AI-based and how well on its duty |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
10 |
What methodological approach did the article emphasize for future AI acceptability studies?
|
Considering user experience and system integration deeply |
|
The studies should go beyond not only focus on the performance only |
Focusing on user and flow in work give more insight rather than speed |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
11 |
What is the primary objective of using human embryonic stem cells in treating Parkinson’s disease?
|
To replace lost dopamine neurons. |
|
Parkinson Diseases is caused by the lack of depamine-producing neuron in brain area |
Using the stem cell to replace missing the dopamine producing neuron may be the solution |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
12 |
Which animal was used to test the STEM-PD product for safety and efficacy?
|
Monkeys |
|
Because their evolution is the closest to us |
Their genetic is similarity to human giving more accurate information |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
13 |
What was the duration of the preclinical safety study in rats mentioned in the article?
|
9 months |
|
To get better result on the study with long-term observation |
It is long enough to see and to study the effect. In case, the effect got too delay |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
14 |
What is the name of the clinical trial phase mentioned for STEM-PD?
|
Phase I/IIa |
|
Both phases combined early safety evaluation and initial testing |
Both phases combined save more time in both stages |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
15 |
How is the STEM-PD product manufactured?
|
|
|
To make the safety and quality for the usage |
GOD'S manufacturer is important for clinal cell therapy |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
16 |
According to the article, what confirmed the safety of the STEM-PD product in rats?
|
There were no adverse effects or tumor formation. |
|
Because there is no dangerous outcome |
It confirmed that it is non-toxic |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
17 |
What key finding was noted in the efficacy study of STEM-PD in rats?
|
Transplanted cells reversed motor deficits in rats. |
|
The result show the STEM-PD was good toward Parkinson symptoms |
This treatment has potential in the Parkinson treatment |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
18 |
What specific markers were used to assess the purity of the STEM-PD batch?
|
FOXA2 and OTX2 |
|
Speficto middle part of the brain |
Both make sure of safety and corrections |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
19 |
What role do growth factors like FGF8b and SHH play in the manufacturing process of STEM-PD?
|
They are used in cell patterning for specific neural fates. |
|
Both guides stem cell to become that specific neuron |
Both make sure cell follow the correct path during the treatment |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
20 |
What was a key outcome measured in the preclinical trials for efficacy in rats?
|
Recovery of motor function |
|
It is the key to measured the outcome show the ability of drugs |
Rats are used to represent human condition and provide more applicable knowledge |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|